Furthermore, we demonstrated that the capacity of the ACE inhibitor, captopril, to ameliorate bleomycin-induced pulmonary fibrosis was entirely dependent on AcPGP accumulation, since protection was abolished by the AcPGP antagonist RTR. This evidence concerns the gene ACE and pulmonary fibrosis.